赛马鲁肽
医学
内科学
2型糖尿病
糖尿病
心脏病学
利拉鲁肽
内分泌学
作者
Steven P. Marso,Stephen C. Bain,Agostino Consoli,Freddy G. Eliaschewitz,Esteban Jódar,Lawrence A. Leiter,Ildiko Lingvay,Julio Rosenstock,Jochen Seufert,Mark Warren,Vincent Woo,Oluf H. Hansen,Anders G. Holst,Jonas Pettersson,Tina Vilsbøll
标识
DOI:10.1056/nejmoa1607141
摘要
In this trial involving patients with type 2 diabetes, the cardiovascular risk profile of oral semaglutide was not inferior to that of placebo. (Funded by Novo Nordisk; PIONEER 6 ClinicalTrials.gov number, NCT02692716.).
科研通智能强力驱动
Strongly Powered by AbleSci AI